In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) released new guidance today recommending the use of popular weight-loss ...

GLP-1s are basically appetite’s off-switch: suddenly you’re “full” after three bites. Congrats on the smaller meals and ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said this ...

The WHO has just released landmark global guidelines recommending for the first time that GLP-1 medicines may be used for long-term treatment of obesity in adults. The move comes as obesity rates ...

Experts say the official recommendation reemphasizes the game-changing ability of GLP-1 medications, but stress that diet and exercise are integral to an effective treatment plan for obesity. The ...

American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by ...

The World Health Organisation (WHO) has released a guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic disease. In September 2025, the WHO added GLP-1 ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...

The World Health Organization has released its first global guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity, recognising the condition as a chronic and relapsing ...